source
- Full-Life Technologies raises $150M; Quince's reboot with pulmonary drugPlus, news about Accro Bioscience, Hansa Biopharma, Shanghai Best-Link Bioscience and UCB. Full-Life Technologies gets $150M: The radiotherapy company has raised $110 million in a Series D round an…Endpoints · 2mo ago↗ source
- Relay drug shows early promise against rare blood vessel diseasesWhile early, the findings suggest the therapy could be superior to Novartis’ Vijoice at treating “vascular anomalies,” a cluster of chronic conditions with few available treatments.BioPharma Dive · 2mo ago↗ source
- Nourish raises $100M for virtual nutrition careNourish, a telehealth platform that arranges virtual appointments with nutritionists, just raised a new round that bumped its valuation to $1.75 billion, according to a person familiar with the mat…